发明名称 Lipid formulations for delivery of messenger RNA
摘要 The present invention provides, among other things, methods of delivering mRNA in vivo, including administering to a subject in need of delivery a composition comprising an mRNA encoding a protein, encapsulated within a liposome such that the administering of the composition results in the expression of the protein encoded by the mRNA in vivo, wherein the liposome comprises a cationic lipid of formula I-c:; or a pharmaceutically acceptable salt thereof.
申请公布号 US9629804(B2) 申请公布日期 2017.04.25
申请号 US201414521161 申请日期 2014.10.22
申请人 Shire Human Genetic Therapies, Inc.;Massachusetts Institute of Technology 发明人 Heartlein Michael;Anderson Daniel;Dong Yizhou;DeRosa Frank
分类号 A61K31/497;A61K9/127;A61K38/17;A61K38/48;A61K38/53;A61K48/00 主分类号 A61K31/497
代理机构 Proskauer Rose LLP 代理人 Proskauer Rose LLP
主权项 1. A method of delivery of messenger RNA (mRNA) in vivo, comprising administering to a subject in need of delivery a composition comprising an mRNA encoding a cystic fibrosis transmembrane conductance regulator (CFTR) protein, encapsulated within a liposome such that the administering of the composition results in the expression of the protein encoded by the mRNA in vivo; wherein the liposome comprises a cationic lipid of formula I-c: or a pharmaceutically acceptable salt thereof, wherein: p is an integer of between 1 and 9, inclusive;each instance of R2 is independently hydrogen or optionally substituted C1-6 alkyl;each instance of L is independently an optionally substituted alkylene, optionally substituted alkenylene, optionally substituted alkynylene, optionally substituted heteroalkylene, optionally substituted heteroalkenylene, optionally substituted heteroalkynylene, optionally substituted carbocyclylene, optionally substituted heterocyclylene, optionally substituted arylene, or optionally substituted heteroarylene, or combination thereof;each instance of R6 and R7 is independently a group of the formula (i), (ii), or (iii);Formulae (i), (ii), and (iii) are: wherein: each instance of R′ is independently hydrogen or optionally substituted alkyl;X is O, S, or NRX, wherein RX is hydrogen, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl, optionally substituted aryl, optionally substituted heteroaryl, or a nitrogen protecting group;Y is O, S, or NRY, wherein RY is hydrogen, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl, optionally substituted aryl, optionally substituted heteroaryl, or a nitrogen protecting group;RP is hydrogen, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl, optionally substituted aryl, optionally substituted heteroaryl, an oxygen protecting group when attached to an oxygen atom, a sulfur protecting group when attached to a sulfur atom, or a nitrogen protecting group when attached to a nitrogen atom; andRL is optionally substituted C1-50 alkyl, optionally substituted C2-50 alkenyl, optionally substituted C2-50 alkynyl, optionally substituted heteroC1-50 alkyl, optionally substituted heteroC2-50 alkenyl, optionally substituted heteroC2-50 alkynyl, or a polymer.
地址 Lexington MA US